First Citizens Financial Corp Bristol Myers Squibb CO Transaction History

First Citizens Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	BUY	$72.62 - $79.98 $9,295 - $10,237	128 Added 3.14%	4,198 $323,000
Q3 2021 Oct 14, 2021	SELL	$59.17 - $69.31 $7,396 - $8,663	-125 Reduced 2.98%	4,070 $241,000
Q1 2021 Apr 09, 2021	SELL	$59.34 - $66.74 $126,750 - $142,556	-2,136 Reduced 33.74%	4,195 $265,000
Q4 2020 Feb 01, 2021	BUY	$57.74 - $65.43 $365,551 - $414,237	6,331 New	6,331 $393,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of First Citizens Financial Corp, based on Form 13F filings with the SEC.

Stay updated on First Citizens Financial Corp with notifications on news.